Prospective evaluation of minimal residual disease in multiple myeloma following autologous stem cell transplantation(ASCT) and consolidation therapy.

被引：0
|
作者：
Patekar, Mukesh
Kumar, Lalit
Sharma, Atul
Gupta, Ritu
Vishnubhatla, Sreenivas
Naik, Ramavath Devendra
Pai, Rohit Ramesh
Tiwari, Akash
Dahiya, Meetu
机构：
[1] AIIMS, New Delhi, India
[2] All India Inst Med Sci, Dept Biostat, New Delhi, India
[3] All India Inst Med Sci, Dr BRA Inst Rotary Canc Hosp, New Delhi, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e20033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20033
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Maintenance Therapy after Autologous Haematopoietic Stem Cell Transplantation (auto-HSCT) in Multiple Myeloma Patients with and without Minimal Residual Disease (MRD)
    Solovev, Maxim V.
    Mendeleeva, Larisa P.
    Pokrovskaya, Olga S.
    Gemdzhian, Eduard G.
    Kuzmina, Larisa A.
    Firsova, Maya
    Galtseva, Irina
    Davydova, Julia
    Savchenko, Valeri G.
    BLOOD, 2016, 128 (22)
  • [32] Long-Term Outcome of Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation (ASCT) - Impact of Therapeutic Strategy Following ASCT
    Martin, Emilie
    Morisset, Stephane
    Sobh, Mohamad
    Quillon, Alfred
    Boyer, Helene
    Rey, Philippe
    Nicolas-Virelizier, Emmanuelle
    Belhabri, Amine
    Guillermin, Yann
    Lebras, Laure
    Mialou, Valerie
    Bourgeot, Jean Paul
    Teyssier, Melinda
    Michallet, Anne-Sophie
    Michallet, Mauricette
    BLOOD, 2023, 142
  • [33] A comparison of 3 staging systems for the outcome following autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM).
    Sohn, HJ
    Kim, K
    Lee, JH
    Bang, SM
    Kim, DH
    Lee, JJ
    Suh, C
    BLOOD, 2005, 106 (11) : 457B - 458B
  • [34] Natural history of multiple myeloma (MM) relapsing after autologous stem cell transplantation (ASCT)
    Madan, S.
    Kumar, S.
    Lacy, M. Q.
    Dispenzieri, A.
    Hayman, S. R.
    Buadi, F. K.
    Dingli, D.
    Rajkumar, S. V.
    Gertz, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [35] Minimal residual disease after allogeneic and autologous stem cell transplant in myeloma
    Owen, RG
    Bybee, A
    Cooke, F
    Haynes, AP
    Johnson, RG
    Smith, GM
    Child, JA
    Russell, NH
    Morgan, G
    Samson, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 620 - 620
  • [36] AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LYMPHOMA: AN EVALUATION OF GRAFTS SOURCE AND MINIMAL RESIDUAL DISEASE
    侯淑玲
    张巧花
    韩维娥
    归薇
    王毓銮
    Chinese Journal of Cancer Research, 2005, (03) : 217 - 223
  • [37] Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
    Liu, Jiahui
    Yan, Wenqiang
    Fan, Huishou
    Xu, Jingyu
    Li, Lingna
    Du, Chenxing
    Mao, Xuehan
    Yan, Yuting
    Xu, Yan
    Sui, Weiwei
    Deng, Shuhui
    Yi, Shuhua
    Anderson, Kenneth C.
    Qiu, Lugui
    Zou, Dehui
    An, Gang
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (09): : 1770 - 1780
  • [38] Prognostic Significance of Minimal Residual Disease Testing by Multiparameter Flow Cytometry in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
    Mostafa, Nevine
    El-Salakawy, Walaa
    Abdelbary, Haitham
    Radwan, Rania
    Fathy, Rasha
    Abouelmagd, Yasmin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S300 - S300
  • [39] Stem Cell Mobilization Capacity Is Not a Predictor of Survival in Multiple Myeloma (MM) After Autologous Stem Cell Transplantation (ASCT)
    Lim, Gloria
    Xu, Wei
    Young, Trieu
    Winter, Andrew
    Reece, Donna E.
    Trudel, Suzanne
    Kukreti, Vishal
    Anglin, Peter
    Chen, Christine
    BLOOD, 2009, 114 (22) : 847 - 847
  • [40] Autologous stem cell transplantation in multiple myeloma
    Louw, V.
    Webb, M. J.
    SOUTHERN AFRICAN JOURNAL OF ANAESTHESIA AND ANALGESIA, 2010, 16 (01) : 57 - 57
12345